참고문헌
- Siegel R, Naishadham D and Jemal A (2012) Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin 62, 283-298 https://doi.org/10.3322/caac.21153
- Lozano R, Naghavi M, Foreman K et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet 380, 2095-2128 https://doi.org/10.1016/S0140-6736(12)61728-0
- Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D (2011) Global cancer statistics. CA Cancer J Clin 61, 69-90 https://doi.org/10.3322/caac.20107
- Bak Y, Kwon T, Bak IS, Hong J, Yu DY and Yoon DY (2016) IL-32theta inhibits stemness and epithelialmesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer. Oncotarget 7, 7307-7317
- Merika E, Saif MW, Katz A, Syrigos K and Morse M (2010) Review. Colon cancer vaccines: an update. In Vivo 24, 607-628
- Bonnet D and Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3, 730-737 https://doi.org/10.1038/nm0797-730
- Jordan CT (2009) Cancer stem cells: controversial or just misunderstood? Cell Stem Cell 4, 203-205 https://doi.org/10.1016/j.stem.2009.02.003
- Lessard J and Sauvageau G (2003) Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255-260 https://doi.org/10.1038/nature01572
- Lee HE, Kim JH, Kim YJ et al (2011) An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer. Br J Cancer 104, 1730-1738 https://doi.org/10.1038/bjc.2011.159
- Gao XM, Zhang R, Dong QZ and Qin LX (2016) Properties and feasibility of using cancer stem cells in clinical cancer treatment. Cancer Biol Med 13, 489-495 https://doi.org/10.20892/j.issn.2095-3941.2016.0076
- Vinogradov S and Wei X (2012) Cancer stem cells and drug resistance: the potential of nanomedicine. Nanomedicine (Lond) 7, 597-615 https://doi.org/10.2217/nnm.12.22
- Jordan MA and Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4, 253-265 https://doi.org/10.1038/nrc1317
- Zhou J and Giannakakou P (2005) Targeting microtubules for cancer chemotherapy. Curr Med Chem Anticancer Agents 5, 65-71 https://doi.org/10.2174/1568011053352569
- Sakchaisri K, Kim SO, Hwang J et al (2017) Anticancer activity of a novel small molecule tubulin inhibitor STK899704. PLoS One 12, e0173311 https://doi.org/10.1371/journal.pone.0173311
- Gialeli C, Theocharis AD and Karamanos NK (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278, 16-27 https://doi.org/10.1111/j.1742-4658.2010.07919.x
- Liang W, Lai Y, Zhu M, Huang S, Feng W and Gu X (2016) Combretastatin A4 regulates proliferation, migration, invasion, and apoptosis of thyroid cancer cells via PI3K/Akt signaling pathway. Med Sci Monit 22, 4911-4917 https://doi.org/10.12659/MSM.898545
- McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG and Frame MC (2005) The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer 5, 505-515 https://doi.org/10.1038/nrc1647
- Pastrana E, Silva-Vargas V and Doetsch F (2011) Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell 8, 486-498 https://doi.org/10.1016/j.stem.2011.04.007
- Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100, 3983-3988 https://doi.org/10.1073/pnas.0530291100
- Goldman RD (1971) The role of three cytoplasmic fibers in BHK-21 cell motility. I. Microtubules and the effects of colchicine. J Cell Biol 51, 752-762 https://doi.org/10.1083/jcb.51.3.752
- Han YS, Lee JH and Lee SH (2015) Fucoidan inhibits the migration and proliferation of HT-29 human colon cancer cells via the phosphoinositide-3 kinase/Akt/mechanistic target of rapamycin pathways. Mol Med Rep 12, 3446-3452 https://doi.org/10.3892/mmr.2015.3804
- Mu Y, Zou H, Chen B, Fan Y and Luo S (2017) FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway. Biomed Pharmacother 90, 548-554 https://doi.org/10.1016/j.biopha.2017.03.073
- Wang YJ, Zhang ZF, Fan SH et al (2017) MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK. Oncotarget 8, 100227-100241
- Deramaudt TB, Dujardin D, Noulet F et al (2014) Altering FAK-paxillin interactions reduces adhesion, migration and invasion processes. PLoS One 9, e92059 https://doi.org/10.1371/journal.pone.0092059
- Pylayeva Y, Gillen KM, Gerald W, Beggs HE, Reichardt LF and Giancotti FG (2009) Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest 119, 252-266
- Schlaepfer DD, Mitra SK and Ilic D (2004) Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim Biophys Acta 1692, 77-102 https://doi.org/10.1016/j.bbamcr.2004.04.008
- Suva ML, Riggi N, Stehle JC et al (2009) Identification of cancer stem cells in Ewing's sarcoma. Cancer Res 69, 1776-1781 https://doi.org/10.1158/0008-5472.CAN-08-2242
- Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T and Moriwaki H (2006) Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 351, 820-824 https://doi.org/10.1016/j.bbrc.2006.10.128
- Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB and Farrar WL (2008) CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer 98, 756-765 https://doi.org/10.1038/sj.bjc.6604242
- Kim WT and Ryu CJ (2017) Cancer stem cell surface markers on normal stem cells. BMB Rep 50, 285-298 https://doi.org/10.5483/BMBRep.2017.50.6.039
- Bak Y, Ham S, Baatartsogt O et al (2013) A1E inhibits proliferation and induces apoptosis in NCI-H460 lung cancer cells via extrinsic and intrinsic pathways. Mol Biol Rep 40, 4507-4519 https://doi.org/10.1007/s11033-013-2544-0
- Bak Y, Kang JW, Kim MS et al (2014) IL-32theta downregulates CCL5 expression through its interaction with PKCdelta and STAT3. Cell Signal 26, 3007-3015 https://doi.org/10.1016/j.cellsig.2014.09.015